CoChat

Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association

Open access
Goldstein, Larry B., Toth, Peter P., Dearborn-Tomazos, Jennifer L., Giugliano, Robert P., Hirsh, Benjamin J., Peña, Jessica M., Selim, Magdy H., Woo, Daniel, on behalf of the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Peripheral Vascular Disease; and Stroke Council · 2023 · Arteriosclerosis, Thrombosis, and Vascular Biology
Cited by 92

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Abstract

The objective of this scientific statement is to evaluate contemporary evidence that either supports or refutes the conclusion that aggressive low-density lipoprotein cholesterol lowering or lipid lowering exerts toxic effects on the brain, leading to cognitive impairment or dementia or hemorrhagic stroke. The writing group used literature reviews, references to published clinical and epidemiology studies, clinical and public health guidelines, authoritative statements, and expert opinion to summarize existing evidence and to identify gaps in current knowledge. Although some retrospective, case control, and prospective longitudinal studies suggest that statins and low-density lipoprotein cholesterol lowering are associated with cognitive impairment or dementia, the preponderance of observational studies and data from randomized trials do not support this conclusion. The risk of a hemorrhagic stroke associated with statin therapy in patients without a history of cerebrovascular disease is nonsignificant, and achieving very low levels of low-density lipoprotein cholesterol does not increase that risk. Data reflecting the risk of hemorrhagic stroke with lipid-lowering treatment among patients with a history of hemorrhagic stroke are not robust and require additional focused study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/atv.0000000000000164

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 89 references

Cited by

See all 92

Metadata

Authors
Goldstein, L. B., Toth, P. P., Dearborn-Tomazos, J. L., Giugliano, R. P., Hirsh, B. J., Peña, J. M., Selim, M. H., Woo, D., & on behalf of the American Heart Association Council on Arteriosclerosis, T. A. V. B. C. O. C. A. S. N. C. O. P. V. D. A. S. C.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2023-10
Volume
43
Issue
10
Pages
e404-e442
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W4386726793
Cited by
92
References
89
FWCI
21.94
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association. https://app.cochat.ai/papers/10.1161/atv.0000000000000164
The paper
Goldstein, L. B., Toth, P. P., Dearborn-Tomazos, J. L., Giugliano, R. P., Hirsh, B. J., Peña, J. M., Selim, M. H., Woo, D., & on behalf of the American Heart Association Council on Arteriosclerosis, T. A. V. B. C. O. C. A. S. N. C. O. P. V. D. A. S. C. (2023). Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atv.0000000000000164

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.